A late-night bidding war for a Californian biotech company has taken the value of healthcare deals in the past 15 months to nearly half a trillion dollars in a fresh sign that sky-high valuations have not slowed the pace of pharmaceuticals dealmaking.
對美國加州一家生物科技公司的深夜競標戰，使過去15個月的醫藥業并購交易總值逼近5000億美元，這一最新跡象表明，天價估值并未放緩制藥業撮合交易的步伐。
您已閱讀7%（326字），剩余93%（4157字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。